McAdam LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Buy	+1,614	New	+$201K	0.01%	406
2025 Q3	–	Sell	-3,273	Closed	-$271K	–	412
2025 Q2	$271K	Buy	3,273 +159	+5%	+$12.7K	0.01%	307
2025 Q1	$253K	Sell	3,114 -3,288	-51%	-$294K	0.02%	285
2024 Q4	$577K	Sell	6,402 -1,248	-16%	-$121K	0.03%	182
2024 Q3	$756K	Sell	7,650 -413	-5%	-$40.6K	0.04%	154
2024 Q2	$748K	Sell	8,063 -3,105	-28%	-$278K	0.05%	145
2024 Q1	$1.06M	Buy	11,168 +2,956	+36%	+$274K	0.07%	113
2023 Q4	$733K	Buy	8,212 +295	+4%	+$21.9K	0.05%	130
2023 Q3	$578K	Sell	7,917 -252	-3%	-$20.1K	0.05%	145
2023 Q2	$680K	Buy	8,169 +34	+0.4%	+$2.84K	0.06%	133
2023 Q1	$620K	Sell	8,135 -1,385	-15%	-$115K	0.06%	136
2022 Q4	$1.07M	Buy	9,520 +654	+7%	+$52.9K	0.11%	74
2022 Q3	$703K	Sell	8,866 -274	-3%	-$23.1K	0.08%	112
2022 Q2	$679K	Sell	9,140 -678	-7%	-$50.9K	0.07%	116
2022 Q1	$882K	Buy	9,818 +298	+3%	+$27.5K	0.08%	86
2021 Q4	$1.07M	Sell	9,520 -726	-7%	-$87.6K	0.11%	74
2021 Q3	$1.29M	Sell	10,246 -1,876	-15%	-$242K	0.14%	67
2021 Q2	$1.52M	Buy	12,122 +3,893	+47%	+$512K	0.17%	63
2021 Q1	$1.12M	Buy	8,229 +4,220	+105%	+$632K	0.16%	61
2020 Q4	$594K	Buy	+4,009	New	+$513K	0.09%	77